Core Viewpoint - Changguang Huaxin (688048) announced that Suzhou Yingrui Venture Capital Partnership (Limited Partnership) plans to reduce its stake in the company by up to 2.613 million shares, representing no more than 1.48% of the total share capital [1] Group 1 - Suzhou Yingrui currently holds 14.82% of Changguang Huaxin's shares [1] - The reduction will occur through centralized bidding and block trading methods [1] - The total number of shares to be reduced is capped at 2.613 million [1]

证券代码：688048 证券简称：长光华芯 公告编号：2025-048 苏州长光华芯光电技术股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东持有的基本情况 截止本公告披露日，苏州英镭创业投资合伙企业（有限合伙）（以下简称"苏 州英镭"）持有苏州长光华芯光电技术股份有限公司（以下简称"长光华芯"或 "公司"）股份 26,130,000 股，占公司总股本的 14.82%，为公司首次公开发行 前取得的股份及公司送股所得，已于 2025 年 10 月 9 日解除限售并上市流通。 减持计划的主要内容 公司于近日收到股东苏州英镭出具的《关于股份减持计划告知函》，因股东 自身资金需求，需要减持公司股份。苏州英镭计划通过集中竞价、大宗交易方式 合计减持数量不超过 2,613,000 股（占公司总股本比例不超过 1.48%），其中： 以集中竞价交易方式减持股份，减持期间为自公司公告披露之日起十五个交易日 后的三个月内，减持数量不超过 1,760,000 股（占公司总股本比 ...

长光华芯公告，苏州英镭创业投资合伙企业计划减持公司股份不超过261.3万股，占公司总股本的比例 不超过1.48%。减持方式包括集中竞价和大宗交易。以集中竞价交易方式减持的股份数量不超过176万 股，占公司总股本比例不超过1%；以大宗交易方式减持的股份数量不超过85.3万股，占公司总股本比 例不超过0.48%。减持期间为2025年11月3日至2026年2月2日，主要因股东自身资金需求。此次减持计 划符合相关法律法规要求。 ...

Core Viewpoint - The semiconductor stocks experienced a significant decline, with several companies seeing drops exceeding 10% due to adjustments in margin financing rates related to high static price-to-earnings ratios [1] Group 1: Stock Performance - Dongxin Co. and Baiwei Storage fell over 11% - Yandong Micro and Jinghe Integration dropped over 10% - Demingli, Huahong, and Purun shares decreased over 8% - Lianyun Technology and Chiplink Integration fell over 7% - Other companies like Hengsuo, Aojie Technology, and Zhongke International saw declines over 6% [1] Group 2: Margin Financing Adjustments - On October 9, margin financing rates for stocks like Zhongke International and Baiwei Storage were reduced to 0 due to their static price-to-earnings ratios exceeding 300 times - Multiple brokerages clarified that this adjustment is a routine operation based on exchange rules established in 2016, applicable to all A-share stocks with similar high static price-to-earnings ratios [1]

Core Insights - Long光华芯's stock price decreased by 0.53% on October 9, with a trading volume of 615 million yuan [1] - The company achieved a revenue of 214 million yuan in the first half of 2025, representing a year-on-year growth of 68.08% [2] - The net profit attributable to shareholders for the same period was 8.97 million yuan, showing a significant increase of 121.13% year-on-year [2] Financing and Trading Activity - On October 9, Long光华芯 had a net financing purchase of 16.11 million yuan, with a total financing balance of 569 million yuan, accounting for 4.28% of its market capitalization [1] - The financing balance is above the 90th percentile of the past year, indicating a high level of financing activity [1] - The short selling activity on the same day included a repayment of 3,081 shares and a sale of 600 shares, with a short selling balance of 54,830 yuan, which is below the 30th percentile of the past year [1] Shareholder and Dividend Information - As of June 30, the number of shareholders for Long光华芯 increased by 9.23% to 14,500, while the average number of circulating shares per shareholder decreased by 2.40% to 7,323 shares [2] - The company has distributed a total of 115 million yuan in dividends since its A-share listing, with 47.46 million yuan distributed over the past three years [3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 1.41 million shares, a decrease of 12.39 million shares from the previous period [3]

Core Viewpoint - On October 9, a total of 11 listed companies had their restricted shares unlocked, with a total market value of approximately 24.303 billion yuan [1] Summary by Category Restricted Share Unlocking - The companies involved in the unlocking of restricted shares include: - Guo Xin Health (000503) with 1.6798 million shares from equity incentive restrictions - Kang Yuan Pharmaceutical (600557) with 315,500 shares from equity incentive restrictions - Sen Te Co., Ltd. (603098) with 270,000 shares from equity incentive restrictions - San Ren Xing (605168) with 165,300 shares from equity incentive restrictions - Hai Liang Data (603138) with 5.6629 million shares from equity incentive restrictions - Tian Yi Medical (301097) with 40.6 million shares from extended lock-up period - Ming Li Da (301268) with 19 million shares from extended lock-up period - Heng Yu Xintong (300965) with 3.51045 million shares from extended lock-up period - Pu Yuan Jing Dian (688337) with 11.8 million shares unlocked - Zhong Fu Shen Ying (688295) with 29.8 million shares unlocked - Chang Guang Hua Xin (688048) with 7.007 million shares unlocked [1]

Group 1 - A total of 13 companies had their restricted shares unlocked on October 9, with a combined unlock volume of 826 million shares, valued at 28.72 billion yuan based on the latest closing prices [1] - Six companies had unlock volumes exceeding 10 million shares, with Zhongfu Shenying, Kangguan Technology, and Puyuan Precision Electronics leading the unlock volumes at 298 million shares, 254 million shares, and 118 million shares respectively [1] - In terms of unlock market value, six companies had unlock values exceeding 100 million yuan, with Zhongfu Shenying, Kangguan Technology, and Changguang Huaxin leading at 8.424 billion yuan, 5.908 billion yuan, and 5.308 billion yuan respectively [1] Group 2 - Six companies had unlock ratios exceeding 10% of their total share capital, with Puyuan Precision Electronics, Hengyu Xintong, and Changguang Huaxin having the highest unlock ratios at 61.0%, 58.51%, and 39.75% respectively [1]

Core Points - The announcement pertains to the listing and circulation of restricted shares for Suzhou Changguang Huaxin Optoelectronics Technology Co., Ltd. [1] - A total of 70,070,000 shares will be listed for circulation, which represents 39.75% of the company's total share capital [6][11] - The listing date for these restricted shares is set for October 9, 2025 [4][11] Summary by Sections 1. Listing Details - The type of stock being listed is restricted shares from the initial public offering (IPO) [2] - The shares will be available for circulation after a lock-up period of 42 months, which includes a mandatory 36 months and an optional 6 months extension [6] 2. Share Capital Changes - Following a stock dividend distribution on June 6, 2023, the company's total share capital increased to 176,279,943 shares [7] 3. Shareholder Commitments - Major shareholders have committed to not transferring or managing their shares for 36 months post-IPO, with specific conditions for potential reductions in shareholding thereafter [9][10] - If the company's stock price falls below the issue price for a specified period, the lock-up period may be extended by an additional 6 months [10] 4. Compliance and Verification - The sponsor institution, Huatai United Securities, has verified that the shareholders have adhered to their commitments regarding the restricted shares [12][13]

Core Viewpoint - Changguang Huaxin announced the listing of its shares, with a total of 70,070,000 shares to be released for trading on October 9, 2025, under a first-time limited sale stock type [1] Summary by Relevant Sections - **Stock Listing Details** - The stock listing type is a first-time limited sale stock [1] - The total number of shares to be listed is 70,070,000 [1] - The listing date for the shares is set for October 9, 2025 [1] - **Subscription Method** - The method of stock subscription is through offline channels [1] - The total number of shares available for circulation equals the entire number of limited sale shares [1]

证券代码：688048 证券简称：长光华芯 公告编号：2025-047 苏州长光华芯光电技术股份有限公司 重要内容提示： 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 70,070,000股。本公司确认，上市流通数量等于该限售期的全部限售股份数量。 本次股票上市流通总数为70,070,000股。 关于首次公开发行部分限售股上市流通的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本次股票上市流通日期为2025 年 10 月 9 日。 一、本次上市流通的限售股类型 根据中国证券监督管理委员会出具的《关于同意苏州长光华芯光电技术股份 有限公司首次公开发行股票注册的批复》（证监许可〔2022〕423 号），公司获准以 首次公开发行方式向社会公众发行人民币普通股 33,900,000 股，并于 2022 年 4 月 1 日在上海证券交易所科创板上市，发行完成后总股本为 135,599,956 股，其中有 限售条件流通股 106,358,675 股，无限售条件流通股 29,241,281 股。 2022 年 ...